Schroeder Mark S (CIK 1793112) reported 12 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-30). Recent activity: Buy LH (9,304 shares), Sell LH (4,600 shares), Buy LH (2,968 shares), Sell LH (1,468 shares), Buy LH (806 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-30 | LABCORP HOLDINGS INC. (LH) | EVP, Pres Diagnostics & COO | Buy | 9,304 | $0 |
| 2026-03-30 | LABCORP HOLDINGS INC. (LH) | EVP, Pres Diagnostics & COO | Sell | 4,600 | $1.2M |
| 2026-03-30 | LABCORP HOLDINGS INC. (LH) | EVP, Pres Diagnostics & COO | Buy | 2,968 | $0 |
| 2026-03-30 | LABCORP HOLDINGS INC. (LH) | EVP, Pres Diagnostics & COO | Sell | 1,468 | $393,982 |
| 2026-02-13 | LABCORP HOLDINGS INC. (LH) | EVP, Pres Diagnostics & COO | Buy | 806 | $0 |
| 2026-02-13 | LABCORP HOLDINGS INC. (LH) | EVP, Pres Diagnostics & COO | Sell | 259 | $75,082 |
| 2026-02-10 | LABCORP HOLDINGS INC. (LH) | EVP, Pres Diagnostics & COO | Buy | 743 | $0 |
| 2026-02-10 | LABCORP HOLDINGS INC. (LH) | EVP, Pres Diagnostics & COO | Sell | 239 | $66,251 |
| 2026-02-10 | LABCORP HOLDINGS INC. (LH) | EVP, Pres Diagnostics & COO | Buy | 517 | $0 |
| 2026-02-10 | LABCORP HOLDINGS INC. (LH) | EVP, Pres Diagnostics & COO | Buy | 164 | $0 |
| 2026-02-10 | LABCORP HOLDINGS INC. (LH) | EVP, Pres Diagnostics & COO | Sell | 166 | $45,486 |
| 2026-02-10 | LABCORP HOLDINGS INC. (LH) | EVP, Pres Diagnostics & COO | Sell | 53 | $14,523 |
来源：SEC Form 4 申报文件 · 截至 2026-03-30